Health Care: Drugs

Array BioPharma Inc. (ARRY: NASDAQ)

$5.86 0.20 | 3.53%
05/24/13 - 03:13 PM ET
Company Income Statement
Jun 2012 Jun 2011 Jun 2010 Jun 2009
Sales 85.14M 71.90M 53.88M 24.98M
Cost of Sales 19.18M 21.30M 21.98M 13.24M
Gross Operating Profit 65.95M 50.60M 31.90M 11.74M
Selling, General, and Administrative Expenses 15.20M 16.26M 17.12M 18.02M
Research & Development 56.72M 63.50M 72.49M 89.56M
Operating Income before D & A (EBITDA) -5.97M -29.16M -57.71M -95.84M
Depreciation & Amortization 5.08M 7.62M 6.34M 6.61M
Interest Income 32.00K 406.00K 864.00K 2.12M
Other Income - Net -942.00K -4.45M 1.30M -17.74M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -11.96M -40.82M -61.88M -118.08M
Interest Expense 11.62M 15.51M 15.75M 10.02M
Pre-Tax Income -23.58M -56.32M -77.63M -128.10M
Income Taxes 0.00 0.00 0.00 -288.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -23.58M -56.32M -77.63M -127.82M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -23.58M -56.32M -77.63M -127.82M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -23.58M -56.32M -77.63M -127.82M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -23.58M -56.32M -77.63M -127.82M
Preferred Dividends
Net Income Available To Common -23.58M -56.32M -77.63M -127.82M
Basic EPS from Continuing Ops. -0.33 -1.02 -1.55 -2.67
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.33 -1.02 -1.55 -2.67
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.33 -1.02 -1.55 -2.67
Basic Normalized Net Income/Share -0.33 -1.02 -1.55 -2.67
EPS fr Continuing Ops. -0.33 -1.02 -1.55 -2.67
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.33 -1.02 -1.55 -2.67
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.33 -1.02 -1.55 -2.67
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -0.33 -1.02 -1.55 -2.67
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ARRY

View All

Latest ARRY Headlines from TheStreet

More Financial News for ARRY

Press Releases for ARRY

See All Press Releases

Partner Headlines for ARRY

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter